Wenbin Zeng

Title: The Innovations of Wenbin Zeng

Introduction

Wenbin Zeng is a notable inventor based in Zhongshan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for medical applications. His work focuses on addressing critical health issues through innovative solutions.

Latest Patents

Wenbin Zeng holds a patent for "Butylphthalide-telmisartan hybrids, preparation method and application thereof." This invention discloses a butylphthalide-telmisartan heterocomplex, along with its preparation method and applications. Specifically, it relates to an optically active ring-opening butylphthalide-telmisartan heterocomplex, or a pharmaceutically acceptable salt or ester thereof. The invention includes a pharmaceutical composition containing these compounds and highlights their application in the prevention and treatment of neuroinflammation-related diseases. These diseases include ischemic stroke, Alzheimer's disease, brain trauma, Parkinson's disease, multiple sclerosis, and depression. Wenbin Zeng has 1 patent to his name.

Career Highlights

Wenbin Zeng is associated with Guangdong Longfu Medicine Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a commitment to developing effective treatments for complex medical conditions.

Collaborations

Wenbin Zeng collaborates with esteemed colleagues such as Zhangjian Huang and Cunfang Wang. Their combined expertise enhances the research and development efforts within their organization.

Conclusion

Wenbin Zeng's contributions to pharmaceutical innovations demonstrate his dedication to improving healthcare outcomes. His patented work on butylphthalide-telmisartan hybrids showcases the potential for new treatments in neuroinflammation-related diseases.